All News about Corcept Therapeutics
![](https://ml.globenewswire.com/media/e5dc3e5e-5c0b-4c82-b865-24470bdff17f/small/corcept-png.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/e5dc3e5e-5c0b-4c82-b865-24470bdff17f/small/corcept-png.png)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Corcept Therapeutics
April 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Corcept Therapeutics's Future
March 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/yiorgos-ntrahas-mcauhlgirvs-unsplash_11_8.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/e5dc3e5e-5c0b-4c82-b865-24470bdff17f/small/corcept-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_2482.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/e5dc3e5e-5c0b-4c82-b865-24470bdff17f/small/corcept-png.png)
Corcept Therapeutics Initiates CATALYST Clinical Trial
March 28, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/e5dc3e5e-5c0b-4c82-b865-24470bdff17f/small/corcept-png.png)
![](https://ml.globenewswire.com/media/e5dc3e5e-5c0b-4c82-b865-24470bdff17f/small/corcept-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4375.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
February 15, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/e5dc3e5e-5c0b-4c82-b865-24470bdff17f/small/corcept-png.png)
![](https://ml.globenewswire.com/media/e5dc3e5e-5c0b-4c82-b865-24470bdff17f/small/corcept-png.png)
![](https://mms.businesswire.com/media/20221228005276/en/1164042/5/July_30%2C_2021_-_ROSEN_LOGO.jpg)
![](https://mms.businesswire.com/media/20221214005733/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](https://mms.businesswire.com/media/20221213006083/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/15/image30.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2018/05/biotechmsn2-compressed.jpg)
![](https://ml.globenewswire.com/media/e5dc3e5e-5c0b-4c82-b865-24470bdff17f/small/corcept-png.png)
![](https://ml.globenewswire.com/media/e5dc3e5e-5c0b-4c82-b865-24470bdff17f/small/corcept-png.png)
Corcept Therapeutics Provides Miricorilant Clinical Development Update
December 08, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/e5dc3e5e-5c0b-4c82-b865-24470bdff17f/small/corcept-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5810.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/e5dc3e5e-5c0b-4c82-b865-24470bdff17f/small/corcept-png.png)
![](https://g.foolcdn.com/editorial/images/705431/businessmen-and-doctors-working-on-touchpad-in-a-hospital.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/wall-street-sign-buildings.jpg)
![](https://ml.globenewswire.com/media/e5dc3e5e-5c0b-4c82-b865-24470bdff17f/small/corcept-png.png)
![](https://www.investors.com/wp-content/uploads/2017/07/watch2.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_23577.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2022
August 01, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.